Seer Reports Mixed Q4/FY25 Results with Flat 2026 Guidance, Holds Cash Exceeding Market Cap

summarizeSummary

Seer, Inc. announced Q4 and full year 2025 financial results, showing modest revenue growth and improved net loss, but provided flat revenue guidance for 2026. The company's cash reserves of over $240 million significantly exceed its market capitalization, providing substantial financial runway.

check_boxKey Events

• Q4 and Full Year 2025 Financial Results

  Seer reported Q4 2025 revenue of $4.2 million (up 5% year-over-year) and full year 2025 revenue of $16.6 million (up 17% year-over-year). The net loss for Q4 2025 was $16.0 million, and for the full year 2025, it was $73.6 million, both improvements over the prior year.

• 2026 Revenue Guidance

  The company expects full year 2026 revenue to be in the range of $16 million to $18 million, representing approximately 3% growth at the midpoint over full year 2025, indicating a slowdown in growth.

• Substantial Cash Reserves

  Seer ended 2025 with approximately $240.6 million in cash, cash equivalents, and investments. This significant cash balance provides a strong financial runway and is notably higher than the company's current market capitalization.

• Operational Growth and Challenges

  The installed base expanded to 82 instruments, representing 67% year-over-year growth. However, the CEO noted 2025 was a challenging year due to ongoing budgetary pressures and uncertainty around NIH funding.

auto_awesomeAnalysis

Seer, Inc. reported a mixed financial performance for Q4 and full year 2025, with modest revenue growth and a reduced net loss. However, the company's 2026 revenue guidance of $16 million to $18 million suggests near-flat growth compared to 2025, indicating ongoing operational challenges and budgetary pressures cited by the CEO. Critically, the company ended 2025 with approximately $240.6 million in cash, cash equivalents, and investments, which significantly exceeds its current market capitalization. This substantial cash position provides a long runway and financial stability, potentially making the company an attractive target for value investors or further activist engagement, especially following the recent 13D filing by an activist investor group on February 20, 2026. While operational growth is slow, the strong balance sheet de-risks the company's near-term future.